Navigation Links
iBio, Inc. and GE Healthcare form new global alliance
Date:7/26/2012

methods.  The iBioLaunch platform also has the potential to manufacture proteins which cannot be commercially produced in any other system.

Worldwide demand for biopharmaceuticals and vaccines is increasing dramatically, driven by ageing populations and the global effort to reduce the incidence of vaccine preventable diseases.  In work funded by the Bill & Melinda Gates Foundation, iBio's pioneering plant-based technology has been used to produce an avian influenza vaccine candidate that recently completed a successful Phase I clinical trial.  The iBioLaunch platform was also used to produce a candidate vaccine against H1N1 influenza, for which a human Phase I trial was successfully completed in March, 2012.  The alliance between the two companies aligns with GE's healthymagination initiative, which focuses on reducing cost, increasing access and improving quality in healthcare.

"We're delighted to form this new global alliance with iBio, who share our vision of bringing affordable and flexible manufacturing capabilities to the producers of these vital, lifesaving medicines.  We look forward to continuing our work with the talented teams at iBio and CMB to explore how this innovative technology could become a commercial reality," said Olivier Loeillot General Manager of Enterprise Solutions at GE Healthcare Life Sciences.

Robert B. Kay, Chairman and CEO of iBio, added, "We are delighted to be extending our alliance with GE Healthcare.  We look forward to working together on the development of a flexible and cost-effective plant-based manufacturing platform that has the potential to assist in the global effort to increase access to biotherapeutics and help reduce the incidence of vaccine preventable diseases."

Commenting on the alliance, Dr. Vidadi Yusibov, Executive Director of CMB, said, "We are pleased to continue and extend our relationship with iBio and GE Healthcare.  The collective experience
'/>"/>

SOURCE iBio, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. iBio, Inc. Prices $10 Million Public Offering
2. iBio, Inc. Submits Plan to Satisfy NYSE Amex Continued Listing Standards
3. New Acquisition Opens Door to Over $230m in Savings for Healthcare Providers
4. Keryx Biopharmaceuticals to Present at The 7th Annual JMP Securities Healthcare Conference
5. InterMune To Present At JMP Securities Healthcare Conference
6. infirst HEALTHCARE Established to Launch Novel Consumer Medicines
7. Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 Healthcare Conference
8. InspireMD to Present at JMP Securities Healthcare Conference on July 12th in New York
9. InspireMD to Present at JMP Securities Healthcare Conferenceon July 12th in New York
10. Healthcare Cloud Computing (Clinical, EMR, SaaS, Private, Public, Hybrid) Market - Global Trends, Challenges, Opportunities & Forecasts (2012 - 2017)
11. Sangamo BioSciences Announces Presentation at Seventh Annual JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013  Cellular Biomedicine Group (OTCQB: CBMG) ... of the total projected enrollment required for its ... preliminary efficacy of the medical technology haMPC (Human ... (KOA). To date the trial has had no ... Phase I open label clinical research trial for ...
(Date:5/17/2013)... May 17, 2013  Insero Health, Inc., a company ... epilepsy and related neurological disorders, is today reporting top-line ... compound INS001 in patients with drug-resistant epilepsy.  The data ... Trials (AED) Xll meeting by Dr. Steven ... of Insero,s Scientific Advisory Board.  In this study, INS001 ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 RURO ... ezColony version 4.1, a versatile refinement to the ... software solution, improves its advanced methodical management for ... with ezColony 4.1. The network-based platform provides user ... effective research. While continuing to emphasize streamlined tasks, ...
(Date:5/17/2013)... Darrington, WA (PRWEB) May 17, 2013 Tooth ... 5th graders showing active signs of the disease. The World ... children and nearly 100% of adults have cavities. What are ... Research is showing a strong connection between the oral ... why is this disease so rampant, yet it is also ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: ... in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded ... the earnings conference call for the fiscal year 2011 ... a.m. Eastern Time on Tuesday, September 27, 2011. ...
... SAN DIEGO, Sept. 20, 2011 The J. ... institute, today held an official groundbreaking ceremony for ... by ZGF Architects, will be a state-of-the-art, "ultra-green" ... computational laboratory building on the University of California, ...
... 20, 2011 SomaGenics, Inc., a biotechnology company specializing ... of RNA interference (RNAi) therapeutics against Hepatitis C virus ... SomaGenics, along with its collaborators at Tekmira Pharmaceuticals ... "Synthetic Short shRNAs are Potent Inhibitors of Hepatitis C ...
Cached Biology Technology:TPI to Host Fiscal Year 2011 Earnings Conference Call on Tuesday, September 27, 2011 at 9:00 a.m. ET 2J. Craig Venter Institute Breaks Ground on La Jolla, California's First True Sustainable Laboratory Facility 2J. Craig Venter Institute Breaks Ground on La Jolla, California's First True Sustainable Laboratory Facility 3SomaGenics' sshRNA Technology Demonstrates Efficacy of RNAi Against Hepatitis C Virus 2SomaGenics' sshRNA Technology Demonstrates Efficacy of RNAi Against Hepatitis C Virus 3
(Date:5/17/2013)... study finds human-caused climate change may have little ... a host of recent studies that predict their ... The findings, which appear in the journal ... survival of a creature thought to be doomed: ... cold-blooded animals, especially forest lizards, will be hard ...
(Date:5/16/2013)... (May 17, 2013) Illustrating a commitment to ... American Gastroenterological Association (AGA) Research Foundation has announced ... Research Fellowship Award recipients. Supported by the National ... (NIDDK), this new award helps underrepresented minority students ... and nutrition research. , "By establishing this new ...
(Date:5/16/2013)... to a fast food restaurant had a higher body ... from fast food, according to researchers at The University ... was particularly strong among those with a lower income. ... American Journal of Public Health indicates higher ... restaurant, and among lower-income African-Americans, the density, or number, ...
Breaking Biology News(10 mins):Climate change may have little impact on tropical lizards 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3
... first time created 3D models of whole intact mouse ... team reports its findings in the May/June issue of ... study published online this week. Combining an ... uses a solution that renders tissue transparent, the researchers ...
... deep ocean animal communities can undergo rapid, widespread and ... are at the forefront of monitoring these changes and ... in a special issue of the journal Deep ... the deep ocean floor as stable, relatively unvarying environment ...
... release is available in German . , ... - a North African bird species with a very ... from attractive males of the same species positively affects ... highly displaying male birds in the experiment were more ...
Cached Biology News:Scientists create 3-D models of whole mouse organs 2Ecological change in the abyss -- the Amperima event 2Ecological change in the abyss -- the Amperima event 3Pleasing to the eye 2Pleasing to the eye 3
Mouse HAI-1 Ectodomain MAb (Clone 199732)...
pETDuet-1 is designed for the coexpression of two target genes....
Human IL-29/IFN-lambda 1 Biotinylated Affinity Purified PAb...
Mouse Laminin-1 MAb (Clone AL-3)...
Biology Products: